KellBenx Receives $10,000,000 Series C Financing Round

  • Feed Type
  • Date
    7/30/2013
  • Company Name
    KellBenx
  • Mailing Address
    3500 Sunrise Highway Building 200 Great River, NY 11739
  • Company Description
    KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood. Our focus is to improve women’s healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders.
  • Website
    http://www.kellbenx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The financing will be used to accelerate clinical trials for its technology.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.